Identifying human herpesvirus 8 infection: performance characteristics of serologic assays.
about
Human herpesvirus 8--a novel human pathogenSeroprevalence of Kaposi's sarcoma-associated herpesvirus and risk factors in Xinjiang, ChinaNovel Kaposi's sarcoma-associated herpesvirus homolog in baboons.Comparison of serologic assays for detection of antibodies against human herpesvirus 8.Assessment of a combined testing strategy for detection of antibodies to human herpesvirus 8 (HHV-8) in persons with Kaposi's sarcoma, persons with asymptomatic HHV-8 infection, and persons at low risk for HHV-8 infection.Detection of antibodies to Kaposi's sarcoma-associated herpesvirus: a new approach using K8.1 ELISA and a newly developed recombinant LANA ELISA.HHV-8 seroprevalence: a global viewHuman herpesvirus type 8 infections among solid organ transplant recipients.Kaposi sarcoma-associated herpesvirus serum DNA and antibodies not associated with subsequent non-Hodgkin lymphoma risk.Highly sensitive assay for human herpesvirus 8 antibodies that uses a multiple antigenic peptide derived from open reading frame K8.1.Socio-economic and other correlates of Kaposi sarcoma-associated herpesvirus seroprevalence among older adults in SicilyPrevalence of human herpesvirus 8 infection in systemic lupus erythematosusUse of a multiantigen detection algorithm for diagnosis of Kaposi's sarcoma-associated herpesvirus infection.Selective killing of Kaposi's sarcoma-associated herpesvirus lytically infected cells with a recombinant immunotoxin targeting the viral gpK8.1A envelope glycoprotein.Rapid Multiplexed Immunoassay for Detection of Antibodies to Kaposi's Sarcoma-Associated HerpesvirusHIV and human herpesvirus 8 co-infection across the globe: Systematic review and meta-analysisCancers associated with Kaposi's sarcoma (KS) in AIDS: a link between KS herpesvirus and immunoblastic lymphomaSexually transmissible infections and prostate cancer riskSeroprevalence and risk factors for human herpesvirus 8 infection, rural EgyptPopulation-based assessment of kaposi sarcoma-associated herpesvirus DNA in plasma among UgandansFour-antigen mixture containing v-cyclin for serological screening of human herpesvirus 8 infection.Seroprevalence of human herpesvirus-8 in HIV-1 infected and uninfected individuals in CameroonHuman herpesvirus 8-associated neoplasms: the roles of viral replication and antiviral treatment.Seroreactivity to Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) latent nuclear antigen in AIDS-associated Kaposi's sarcoma patients depends on CD4+ T-cell count.Prevalence of, and risk factors for Kaposi's sarcoma-associated herpesvirus infection among blood donors in Brazil: a multi-center serosurvey.Comparative study of Kaposi's sarcoma-associated herpesvirus serological assays using clinically and serologically defined reference standards and latent class analysisHuman herpesvirus 8 (HHV-8) infection in healthy urban employees from Greece: seroprevalence and associated factors.Longitudinal analysis of the humoral response to Kaposi's sarcoma-associated herpesvirus after primary infection in children.Seroprevalence of human herpes virus 8 antibody in populations at high or low risk of transfusion, graft, or sexual transmission of viruses.Kaposi's sarcoma associated herpesvirus in a rural Ugandan cohort: 1992-2008.Prevalence of Kaposi's sarcoma-associated herpesvirus infection in sex workers and women from the general population in Spain
P2860
Q24530670-64924251-325E-4F79-B7F5-8488028079ADQ28750969-E7986811-28E7-4BBD-B282-7562846C6BEAQ30452901-1574D40B-275B-4327-A7A1-FD978977EEC8Q33999426-9DDBF170-E8E2-4A80-8F73-A22B96524529Q34193434-D9FAA654-EE8C-4690-9FF7-8DA344ADBC5EQ34309014-999484CA-11EC-4181-947D-A755DA938D1CQ34403845-AAB03F97-60FB-4C35-B59E-190D5F4273C6Q34722916-E3C7686B-3E18-43A0-9AD4-6BF0C1936EBFQ34778288-EAEACF2E-760D-4AE6-9D11-26211FF6641EQ34943123-BD08D6C8-A2F6-4116-97A3-9647461C6D3AQ35004900-3F4F308F-DFB8-49F3-9BCF-7173E9585C3FQ35049426-708B28CC-57D7-4F06-AE58-DDA3AB95E168Q35073499-2823F012-C0D7-49BE-AA3C-809DB42E25DCQ35992503-95766AE4-85A4-41F8-939E-42895139D93BQ36145066-AC330E4A-2FC8-42ED-9361-882FC9FE20D6Q36167185-C0B4D108-A431-4875-93BF-881AB07A851AQ36643922-39E65832-D232-405F-BB40-16DE77240935Q36920062-BD4E5285-7F05-48C0-9F01-4ED6C5D19D9AQ36944934-AB194AAB-BDCA-45E9-BAF1-4A70CD583E43Q37128291-7ED44F6E-F703-4087-8892-453D00E60BF0Q37190897-A41AA038-5BB6-4D0D-BAE3-7D9E649F60D7Q37235307-56E24A64-48AD-49F3-BEDB-EF171247063FQ37888397-5D2DA649-9896-465B-AAC2-9A0F28BC8EEEQ38967305-1F986941-9409-4B5B-9164-A8C9EDAD9217Q39294386-5E33595D-CC01-4A12-BB94-8140BFD0C5ACQ39294399-472FC574-BB9D-4F37-8454-EB8B6F6BD24EQ39791344-6CB586EE-9901-4052-9809-326BF9771BEBQ40721567-3E0DDFFB-7B82-43DB-BD6F-43F6B21E8728Q45735713-2094BD67-1B83-4C30-9620-C35303B6B8A1Q46331744-D9FD5B5F-AE3D-4E8C-9E37-DA50E5DB29ACQ58296693-81B017B4-76A8-4972-84F6-DD8BA9F58035
P2860
Identifying human herpesvirus 8 infection: performance characteristics of serologic assays.
description
2000 nî lūn-bûn
@nan
2000年の論文
@ja
2000年学术文章
@wuu
2000年学术文章
@zh
2000年学术文章
@zh-cn
2000年学术文章
@zh-hans
2000年学术文章
@zh-my
2000年学术文章
@zh-sg
2000年學術文章
@yue
2000年學術文章
@zh-hant
name
Identifying human herpesvirus ...... teristics of serologic assays.
@en
Identifying human herpesvirus ...... teristics of serologic assays.
@nl
type
label
Identifying human herpesvirus ...... teristics of serologic assays.
@en
Identifying human herpesvirus ...... teristics of serologic assays.
@nl
prefLabel
Identifying human herpesvirus ...... teristics of serologic assays.
@en
Identifying human herpesvirus ...... teristics of serologic assays.
@nl
P2093
P1476
Identifying human herpesvirus ...... teristics of serologic assays.
@en
P2093
Goedert JJ
P304
P356
10.1097/00126334-200004010-00011
P407
P577
2000-04-01T00:00:00Z